| Cheplapharm Schweiz GmbH - Tarceva 150 mg, Filmtabletten | | 57266 | | 03 | | Tarceva 150 mg | | Filmtabletten | | L01EB02 | | Erlotinib | | 29.08.2007 | | |
| | Composition | | erlotinibum 150 mg ut erlotinibi hydrochloridum 163.93 mg, lactosum monohydricum 103.82 mg, cellulosum microcristallinum, carboxymethylamylum natricum A et natrii laurilsulfas corresp. natrium 9 mg, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, macrogolum 400, E 171, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Erlotinib | 150 mg |
| | BAG: Active Agent | Dose |
|---|
| Erlotinib | 150 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 103.82 mg | | | Macrogol | 400 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Pro Compresso Obducto | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 30 Tablet(s) | 2064.16 | 2261.30 | A | SL | No |
|
|
